Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - STOCK-BASED COMPENSATION
Stock-based Compensation KALV - KalVista Pharmaceuticals, Inc.
21.9 M
LAST VALUE
40.60%
2 YEAR CAGR
49.18%
5 YEAR CAGR
57.19%
10 YEAR CAGR